Mergers & Acquisitions Mergers & Acquisitions

Illumina files Grail buyout for EU review after French referral

By Natalie McNelis
  • 16 Jun 2021 17:44
  • 17 Jun 2021 04:35
Illumina filed its request for EU approval to buy cancer-testing company Grail on Wednesday, MLex has learned. 

The European Commission updated its website with the deal on Thursday, and set a deadline of July 22 to decide on the transaction.*

The US gene-sequencing company made the filing at the request of the commission, which assumed

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News